RE.DOCTOR 通过开发无创血糖监测系统 (BGM)，设计出了一种无创、方便、低成本的糖尿病前期解决方案。
糖尿病及其相关后果预计将成为全球范围内的一个重大问题，预计到 2020 年，全球将有超过 50 亿人患糖尿病。 到 2030 年，每两名糖尿病患者中就有一人未得到诊断。
大幅提高 2 型糖尿病（T2DM）等慢性病管理水平的潜力在很大程度上仍未得到开发。
通过监测血糖水平、 RE.DOCTOR 提供了先发制人地识别糖尿病前期患者的能力，并有可能让糖尿病患者动态管理治疗，从而更好地控制血糖。
RE.DOCTOR 利用信号处理、PPG 技术和人工智能 (AI) 方面的最新技术进步来评估葡萄糖调节功能受损的风险。
通过手机应用程序收集的搏动间期数据可让人工智能模型计算出与糖尿病前期或 T2DM 症状相关的数字生物标志物，并显示患糖尿病的风险。
2021 年
大约 5.37 亿成年人 (20-79 岁）的糖尿病患者。
- 预计糖尿病患者总数将增至 到 2030 年达到 6.43 亿人 和 到 204 年达到 7.83 亿美元5.
- 四分之三 成人糖尿病患者 生活在中低收入国家
- 近二分之一（2.4 亿人） 成人糖尿病患者未得到诊断
- 导致糖尿病 670 万人死亡
- 糖尿病至少导致 9,660 亿美元 医疗卫生支出？占成人总支出的 9%
- 120 多万儿童 和青少年 (0-19 岁）患有 1 型糖尿病
- 每 6 个活产婴儿中就有 1 个 (2100万人）在怀孕期间受到糖尿病的影响
- 5.41 亿 成人患 2 型糖尿病的风险增加
糖尿病前期的事实与数据
"(《世界人权宣言》) IDF 糖尿病图谱 2021 年第 10 版 提供有关全球糖尿病的最新数字、信息和预测。
在以下网站下载 IDF 糖尿病图谱第 10 版 2021 及其他资源 www.diabetesatlas.org.
目前、 第一型糖尿病 是无法预防的。目前仍在研究导致人体胰岛素分泌细胞遭到破坏的糖尿病前期环境诱因。
虽然有许多因素影响着 第二型糖尿病显然，影响最大的是通常与城市化相关的生活方式行为。
其中包括食用不健康食品和久坐不动的不积极生活方式。世界各地的研究表明 改变生活方式 与 体育活动 和/或 健康饮食 可以延缓或预防 2 型糖尿病的发病。
现代生活方式 其特点是缺乏运动和长期久坐不动。 社区干预措施 可以通过运动、教育、社会营销来影响个人和家庭，并鼓励在校内外和工作场所开展体育活动。IDF 建议 体育活动 至少在 每周三至五天，每次至少 30-45 分钟.
以 生命历程视角 对预防 2 型糖尿病及其并发症至关重要。在生命的早期，饮食和体育锻炼习惯已经养成，能量平衡的长期调节可能已经形成，此时是预防超重和降低 2 型糖尿病风险的关键时期。健康的生活方式还能改善晚年的健康状况。
Pioneering the Future of Diabetes Prevention and Management
Insulin resistance is a serious health condition that can lead to type 2 diabetes, heart disease, and other chronic health problems. It is estimated that over 1 billion people worldwide have insulin resistance.
Traditional treatments for insulin resistance focus on lowering blood sugar levels, but they do not address the underlying cause of the problem. AI-driven lifestyle modification is a new approach to reversing insulin resistance that is based on the latest scientific research.
This approach uses artificial intelligence to create personalized plans for diet, exercise, and sleep that are designed to improve insulin sensitivity. These plans are based on each individual?s unique health data and lifestyle factors.
Early studies have shown that AI-driven lifestyle modification can be an effective way to reverse insulin resistance and improve overall health. In one study, participants who followed an AI-driven lifestyle modification plan for six months were able to reduce their body fat by 5%, increase their muscle mass by 3%, and lower their blood sugar levels by 15%.
AI-driven lifestyle modification is a safe and effective way to reverse insulin resistance and improve overall health. It is a personalized approach that is tailored to each individual?s needs.
Here are some of the benefits of AI-driven lifestyle modification:
- Improves insulin sensitivity
- Lowers blood sugar levels
- Reduces body fat
- Increases muscle mass
- Improves heart health
- Reduces the risk of type 2 diabetes and other chronic health problems
If you are interested in learning more about AI-driven lifestyle modification, please talk to RE.DOCTOR
Learn the benefits of combining medication with digital diabetes therapeutics
- Pharmaceutical Companies Embrace Digital Diabetes Therapeutics (DTx) with RE.DOCTOR?s Innovative Solutions
In the ever-evolving healthcare landscape, pharmaceutical companies are continuously seeking innovative ways to enhance their treatment offerings. In this pursuit, digital therapeutics (DTx) have emerged as a transformative force, offering a personalized and data-driven approach to complement traditional pharmacotherapy. Leading the charge in this realm is RE.DOCTOR, a pioneer in DTx solutions, empowering pharmaceutical companies to seamlessly integrate DTx into their treatment strategies.
RE.DOCTOR?s comprehensive DTx platform seamlessly integrates with existing pharmaceutical products, providing a holistic approach to patient care. This integration enables seamless data exchange between DTx and pharmacotherapy, fostering a deeper understanding of patient responses and treatment outcomes. By leveraging RE.DOCTOR?s DTx solutions, pharmaceutical companies can:
- Enhance patient engagement and adherence through personalized interventions
- Provide real-time monitoring of patient progress and treatment efficacy
- Gather valuable data to inform future drug development and clinical trials
The integration of RE.DOCTOR?s DTx solutions into pharmaceutical treatment plans offers a multitude of benefits for patients. DTx can provide:
- Personalized guidance and support for lifestyle modifications
- Remote monitoring and symptom management
- Enhanced self-efficacy and empowerment in managing their health conditions
Through its collaboration with pharmaceutical companies, RE.DOCTOR is revolutionizing the healthcare industry, paving the way for a future where DTx seamlessly complements pharmacotherapy to deliver personalized, data-driven, and patient-centric care.
Additional resources:
- The American Diabetes Association: https://www.diabetes.org/
- The National Institute of Diabetes and Digestive and Kidney Diseases: https://www.niddk.nih.gov/
- The Centers for Disease Control and Prevention: https://www.cdc.gov/
这 研究 证明了智能手机测量的 PPG 经深度学习分析后可用作 无创数字生物标记 糖尿病的发病率。
如需任何帮助和信息，请联系 帮助和信息
我们的解决方案不能替代医疗保健专业人员，也不能诊断、预防或治疗任何形式的疾病。
???? 
English 
Español de México 
Bahasa Indonesia 
Français 
Deutsch 
Italiano 
Türkçe 
Nederlands 
Español 
???? 
???? 
Deutsch (Schweiz, Du) 
???????